These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4818699)

  • 21. [Effect of dopamine on hemodynamics and renal function in patients with severe congestive heart failure].
    Ramdohr B; Schüren KP; Biamino G; Schröder R
    Klin Wochenschr; 1973 Jun; 51(11):549-56. PubMed ID: 4724839
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
    Leier CV; Heban PT; Huss P; Bush CA; Lewis RP
    Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
    el Allaf D; Cremers S; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S49-55. PubMed ID: 6085239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H; Faxon DP; Berkoben J; Brunner HR; Ryan TJ
    Circulation; 1978 Nov; 58(5):770-6. PubMed ID: 699246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
    LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
    Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
    [No Abstract]   [Full Text] [Related]  

  • 26. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind haemodynamic study of a new dopamine derivative (diisobutyric ester of N-methyl-dopamine) orally active in chronic congestive heart failure.
    Mengeot P; Piette F; Mirgaux M
    G Ital Cardiol; 1981; 11(11):1738-42. PubMed ID: 7343377
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use and misuse of vasoactive agents in acute circulatory failure.
    Vincent JL
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S5-9. PubMed ID: 6085240
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F; Guardigli G; Cappelli M; Bernardi P
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of dopegit on indices of central, cerebral, and renal hemodynamics in patients with hypertension].
    Petrov NM; Pishchulina ES; Logacheva IV
    Kardiologiia; 1974 Jun; 14(6):45-50. PubMed ID: 4444132
    [No Abstract]   [Full Text] [Related]  

  • 33. The beneficial effects of chlorpromazine on pulmonary hemodynamics after cardiopulmonary bypass.
    Borman JB; Merin G; Majblum S; Milwidsky H; Cotev S
    Ann Thorac Surg; 1971 Jun; 11(6):570-6. PubMed ID: 5579105
    [No Abstract]   [Full Text] [Related]  

  • 34. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Loeb HS; Bredakis J; Gunner RM
    Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulatory response to vasodilator therapy in congestive cardiomyopathy.
    Rossen RM; Alderman EL; Harrison DC
    Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic effect of sublingual nifedipine in patients with congestive heart failure.
    Wasir HS; Sood AK
    Indian Heart J; 1984; 36(1):8-14. PubMed ID: 6706374
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the hemodynamic effects of intravenous Trinitrine. Applications to the vasodilator treatment of heart failure, myocardial infarct, and mitral insufficiency].
    Baligadoo S; Ingrand JC; Derrida JP; Savier CH; Chiche P
    Coeur Med Interne; 1978; 17(2):231-42. PubMed ID: 95918
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic effects of intravenous administration of dipyridamole].
    De Ponti C; Bardi U
    Cuore Circ; 1970 Oct; 54(5):247-58. PubMed ID: 5503047
    [No Abstract]   [Full Text] [Related]  

  • 40. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.